Shares in InfuSystem (NYSE:INFU) ticked up slightly today after the company reported its fourth-quarter and full-year financial results.
The Michigan-based company posted a net loss of -$275k, or -1¢ per share, on sales of $17.6 million for the three months ended Dec. 31. Sales were down 7% compared to the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post InfuSystem reports Q4, FY18 financial results appeared first on MassDevice.